成人重症监护病房患者血流感染的现状分析:中国多中心队列研究
该前瞻性队列研究自2021年7月1日至2022年12月31日纳入全国16个省市67家医院ICU中疑似血流感染(BSI)的成人患者2 962例,其中BSI组790例、非BSI组2 172例。BSI组以华东、西南地区为主,年龄和病死率显著高于非BSI组;BSI患者中葡萄球菌属检出率最高(8.10%),其次为肺炎克雷伯菌(7.47%);耐药组169例、非耐药组621例;存活666例、死亡124例,病死率15.70%。多因素Logistic回归显示年龄、地区分布、屎肠球菌感染和肺炎克雷伯菌感染是ICU BSI患者死亡的独立危险因素;年龄、革兰阴性杆菌感染、大肠埃希菌感染和屎肠球菌感染是耐药的独立危险因素。作者认为BSI可能增加ICU患者病死率,革兰阴性杆菌引起的血流感染易耐药但对病死率无显著影响。
要点
- 67家医院ICU疑似BSI患者2 962例中BSI组790例,BSI组病死率显著高于非BSI组,BSI患者总病死率15.70%(124/790)。
- BSI患者病原体检出率:葡萄球菌属最高(8.10%),其次肺炎克雷伯菌(7.47%)。
- 死亡独立危险因素:年龄(OR=1.01,95%CI 1.00-1.03)、地区分布(OR=4.07,95%CI 1.02-1.34)、屎肠球菌感染(OR=3.64,95%CI 1.16-11.45)、肺炎克雷伯菌感染(OR=2.64,95%CI 1.45-4.80),均P<0.05。
- 耐药独立危险因素:年龄(OR=1.01,95%CI 1.00-1.03)、G-杆菌感染(OR=2.18,95%CI 1.33-3.59)、大肠埃希菌感染(OR=0.28,95%CI 0.09-0.84)、屎肠球菌感染(OR=3.35,95%CI 1.06-10.58),均P<0.05。
- 耐药组169例、非耐药组621例;G-杆菌血流感染易耐药,但对ICU BSI患者病死率无显著影响。
适用人群与场景
- 全国16个省市67家医院ICU住院期间疑似血流感染的成人患者2 962例,其中BSI组790例、非BSI组2 172例。
诊断标准与关键阈值
- 按有无血流感染分为BSI组与非BSI组;BSI患者再按有无耐药分为耐药组(169例)与非耐药组(621例)。
- 单因素分析中P<0.10的变量纳入多因素Logistic回归分析,以识别ICU BSI患者死亡和耐药的危险因素。
研究设计与关键结果
- 前瞻性队列研究,纳入全国16个省市67家医院ICU疑似BSI成人患者2 962例,采集性别、年龄、住院时间、诊断结果、实验室检查、影像学、微生物学结果(含涂片、培养及病原体高通量检测)和预后。
- BSI组患者主要来自华东和西南地区,年龄和病死率显著高于非BSI组。
- BSI患者中葡萄球菌属检出率最高(8.10%),其次为肺炎克雷伯菌(7.47%)。
- BSI患者中存活666例、死亡124例,病死率15.70%。
- 死亡组与存活组在年龄、地区分布及革兰阴性(G-)杆菌、屎肠球菌、曲霉、肺炎克雷伯菌所致血流感染方面差异有统计学意义。
- 多因素Logistic回归:年龄(OR=1.01,95%CI 1.00-1.03)、地区分布(OR=4.07,95%CI 1.02-1.34)、屎肠球菌感染(OR=3.64,95%CI 1.16-11.45)、肺炎克雷伯菌感染(OR=2.64,95%CI 1.45-4.80)为ICU BSI患者死亡的独立危险因素(均P<0.05)。
- 耐药组与非耐药组在年龄及革兰阳性(G+)球菌、G-杆菌所致血流感染方面差异有统计学意义。
- 多因素Logistic回归:年龄(OR=1.01,95%CI 1.00-1.03)、G-杆菌感染(OR=2.18,95%CI 1.33-3.59)、大肠埃希菌感染(OR=0.28,95%CI 0.09-0.84)、屎肠球菌感染(OR=3.35,95%CI 1.06-10.58)为ICU BSI患者耐药的独立危险因素(均P<0.05)。
证据类型、等级与局限
- 证据类型:前瞻性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血流感染可能增加ICU患者病死率;年龄较大、特定地区分布、屎肠球菌感染和肺炎克雷伯菌感染可增加ICU BSI患者病死率。
- 作者认为G-杆菌引起的血流感染易耐药,但对ICU BSI患者病死率无显著影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the clinical characteristics, microbiological analysis, and drug resistance patterns of intensive care unit (ICU) bloodstream infection.
METHODS: A prospective cohort study method was employed to collect clinical data from patients suspected of bloodstream infection (BSI) during their stay in ICUs across 67 hospitals in 16 provinces and cities nationwide, from July 1, 2021, to December 31, 2022. Electronic data collection technology was used to gather general information on ICU patients, including gender, age, length of hospital stay, as well as diagnostic results, laboratory tests, imaging studies, microbiological results (including smear, culture results, and pathogen high-throughput testing), and prognosis. Patients were divided into a BSI group and a non-BSI group based on the presence or absence of BSI; further, patients with BSI were categorized into a drug-resistant group and a non-drug-resistant group based on the presence or absence of drug resistance. Differences in the aforementioned indicators between groups were analyzed and compared; variables with P < 0.10 in the univariate analysis were included in a multivariate Logistic regression analysis to identify risk factors for mortality and drug resistance in ICU patients with BSI.
RESULTS: A total of 2 962 ICU patients suspected of BSI participated in the study, including 790 in the BSI group and 2 172 in the non-BSI group. Patients in the BSI group were mainly from East China and Southwest China, with significantly higher age and mortality rates than those in the non-BSI group. Among ICU patients with BSI, Staphylococcus had the highest detection rate (8.10%), followed by Klebsiella pneumoniae (7.47%); there were 169 cases in the drug-resistant group and 621 cases in the non-drug-resistant group; 666 cases survived, and 124 cases died (mortality was 15.70%). There were statistically significant differences between the death group and the survival group in terms of age, regional distribution, and bloodstream infections caused by Gram negative (G-) bacilli, Enterococcus faecium, Aspergillus, and Klebsiella pneumoniae; multivariate Logistic regression analysis showed that age [odds ratio (OR) = 1.01, 95% confidence interval (95%CI) was 1.00-1.03], regional distribution (OR = 4.07, 95%CI was 1.02-1.34), Enterococcus faecium infection (OR = 3.64, 95%CI was 1.16-11.45), and Klebsiella pneumoniae infection (OR = 2.64,95%CI was 1.45-4.80) were independent risk factors for death in ICU patients with BSI (all P < 0.05). There were statistically significant differences between the drug-resistant group and the non-drug-resistant group in terms of age and bloodstream infections caused by Gram positive (G+) cocci and G- bacilli; multivariate Logistic regression analysis showed that age (OR = 1.01,95%CI was 1.00-1.03), G- bacilli infection (OR = 2.18, 95%CI was 1.33-3.59), Escherichia coli infection (OR = 0.28,95%CI was 0.09-0.84), and Enterococcus faecium infection (OR = 3.35, 95%CI was 1.06-10.58) were independent risk factors for drug resistance in ICU patients with BSI (all P < 0.05).
CONCLUSIONS: Bloodstream infections may increase the mortality of ICU patients. Older age, regional distribution, Enterococcus faecium infection and Klebsiella pneumoniae infection can increase the mortality rate of ICU patients with BSI; bloodstream infections caused by G- bacilli are prone to drug resistance, but have no significant impact on the mortality of ICU patients with BSI.
参考来源
- Yang S, Sun Y, Wang T, et al. [Current analysis of bloodstream infections in adult intensive care unit patients: a multi-center cohort study of China]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40201992. doi:10.3760/cma.j.cn121430-20240923-00791
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。